KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2026)

Aquestive Therapeutics has reported Change in Inventory over the past 9 years, most recently at -$1.7 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 75.44% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached $126000.0, up 117.38%, while the annual FY2025 figure was $126000.0, 117.38% up from the prior year.
  • Change in Inventory for Q4 2025 was -$1.7 million at Aquestive Therapeutics, down from -$241000.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $1.7 million in Q3 2022 and troughed at -$1.7 million in Q4 2025.
  • A 5-year average of $185500.0 and a median of $196500.0 in 2021 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: surged 7054.17% in 2022 and later plummeted 538.18% in 2025.
  • Year by year, Change in Inventory stood at $1.2 million in 2021, then plummeted by 180.34% to -$944000.0 in 2022, then surged by 67.16% to -$310000.0 in 2023, then tumbled by 215.16% to -$977000.0 in 2024, then tumbled by 75.44% to -$1.7 million in 2025.
  • Business Quant data shows Change in Inventory for AQST at -$1.7 million in Q4 2025, -$241000.0 in Q3 2025, and $927000.0 in Q2 2025.